The Clinical Trials on Alzheimer's Disease conference (CTAD) is a meeting focused entirely on Alzheimer’s Disease Therapeutic Trials
San Diego, CA, USA
Joined April 2017
- Tweets5.9K
- Following332
- Followers3.3K
- Likes2.2K
Meet the six #CTAD26 Rising Stars, presenting in Boston with the support of the Alzheimer’s Association. ctad-alzheimer.com/rising-st…
One week left to submit your CTAD26 abstract. Deadline: September 3. #CTAD26
ctad-alzheimer.com/call-abst…
New at #CTAD26: Real-World Data, Registries & Implementation Science.
From clinical trials to real-world impact: share your data, registries & implementation strategies.
⏳ 3 weeks left to submit!
📅 Deadline: Sept 3
Submit: ctad-alzheimer.com/call-abst…
Space for in-person attendance at #CTAD26 is limited.
#CTAD26 takes place November 16-19, 2026 in Boston, MA.
Securing your registration early is the most reliable way to guarantee your seat.
Register now: ctad-alzheimer.com/registrat…
One month left. #CTAD26 Late Call for Abstracts closes September 3. Discover our submission categories: ctad-alzheimer.com/call-abst…
#CTAD26 Rising Stars Showcase: open to early-career AD/ADRD investigators from any country.
Deadline Sept 3.
Selected presenters get a flash slot in Boston + ISTAART membership + Alzheimer's Association breakfast with senior trialists.
ctad-alzheimer.com/abstracts…
#CTAD26 Late Call for Abstracts is now open, closing September 3 (11:59 PM PT). All topic categories eligible, including Biotech Showcase. Submit now.
ctad-alzheimer.com/call-abst…
The CTAD26 team is on-site at AAIC 2026 in London through July 15.
Find us at Booth #112 to talk Biotech Showcase, Rising Stars, and CTAD26.
Meeting requests: [email protected]. #CTAD26
CTAD26 at AAIC 2026, London.
Booth #112, July 12-15.
Stop by for the preliminary program, the Rising Stars Showcase (with the Alzheimer's Association/ISTAART), and the Biotech Showcase, now in the main plenary room.
Book a time: [email protected]
#CTAD26 #AAIC26
🚨Only a few rooms left at the Sheraton Boston at the CTAD negotiated rate.
$399 USD/night (before taxes)
🔗 book.passkey.com/go/CTADOver…
#CTAD26 #AlzheimerResearch #ClinicalTrials
CTAD has negotiated special rates for its participants at the Sheraton Boston Hotel connected to the conference venue via the Copley Center.
Rooms are available at $399USD before taxes and available via this link: book.passkey.com/go/CTADOver…
"There is no better place to continue that work than here in Boston, and we look forward to welcoming you all."
We invite you to read the full welcome message from Dr. Reisa Sperling and discover the vision shaping #CTAD26 at: ctad-alzheimer.com/program/e…
#ClinicalTrials #ADRD
Meet the 4 companies selected for the #CTAD2026 Biotech Showcase: NeuroTherapia, Circular Genomics, Sinaptica Therapeutics & KVM Therapeutics
Your innovation could be next, submit by September 3: ctad-alzheimer.com/call-abst…
#CTAD26 #BiotechShowcase #AlzheimersDisease #ADDF
The preliminary program also showcases a wide range of poster presentations covering #biomarker research, #imaging, digital tools, trial design, and new #therapeutic approaches.
Register: ctad-alzheimer.com/registrat…
Program: ctad-alzheimer.com/program
#CTAD26 #ADRD #ClinicalTrials
The preliminary program is now live, and oral communications will spotlight some of the field’s most exciting directions: #biomarkers, #imaging, digital assessments, #clinicaltrial design, novel therapies, and real-world evidence.
Program: ctad-alzheimer.com/program
#CTAD26 #ADRD
🔬 The #CTAD26 preliminary program is now available!
World leaders in #Alzheimer's #research & drug development. Late-breaking #trial results. Cutting-edge science shaping the future of #AD treatment.
📍 Boston, MA | 🗓️ November 16–19, 2026
🔗 ctad-alzheimer.com/
CTAD retweeted
The ADDF and @CTADconference are partnering to advance emerging biotech innovation at CTAD 2026 and build momentum toward a new era of Alzheimer's treatments. Learn more about the CTAD 2026 Biotech Showcase and opportunities for participating companies.
🔗bit.ly/3QoMkSk
Lifetime Achievement Award in #AlzheimersDisease Therapeutic #Research
This year’s award goes to Jeffrey Cummings, MD, ScD, in recognition of his outstanding contributions to #Alzheimer’s disease research, clinical trial methodology, and drug development.
#CTAD2026 #BrainHealth
🔬 New at #CTAD2026: Biotech companies pitch live in the main ballroom — 3-min talks + Q&A, supported by the Alzheimer’s Drug Discovery Foundation.
📍 Boston | Nov 16–19, 2026
#BiotechShowcase #AlzheimersResearch #Neuroscience
⏳ Submit your abstract for #CTAD2026!
Deadline: June 2, 2026
CTAD 2026 will feature a rich scientific program covering Alzheimer's clinical research.
📅 Nov 16–19, 2026 | Boston, MA, USA
👉 Submit now: ctad-alzheimer.com/call-abst…
#CTAD2026 #Alzheimer #ClinicalTrials
